Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-010020
Filing Date
2025-04-03
Accepted
2025-04-03 17:30:04
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 form4-04032025_090458.html 4  
1 form4-04032025_090458.xml 4 9090
  Complete submission text file 0001415889-25-010020.txt   10656
Mailing Address MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142
Business Address
Gottlieb Scott (Reporting) CIK: 0001411359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42130 | Film No.: 25811086

Mailing Address 600 WEST CHICAGO AVENUE SUITE 510 CHICAGO IL 60654
Business Address 600 WEST CHICAGO AVENUE SUITE 510 CHICAGO IL 60654 800-976-5448
Tempus AI, Inc. (Issuer) CIK: 0001717115 (see all company filings)

EIN.: 474903308 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7370 Services-Computer Programming, Data Processing, Etc.
(CF Office: 06 Technology)